ABSTRACT
Background Influenza (flu) and COVID-19 vaccination rates are subpar across the US, especially in racial and/or socioeconomic minority groups who are understudied in public health literature.
Objective The objective of this study was to elucidate the attitudes of Turtle Creek patients towards flu and COVID-19 vaccines, with the goal of establishing targetable vaccine education gaps and ultimately increasing vaccine uptake in the community.
Design/Patients This study was conducted as a retrospective cross-sectional analysis. Authors completed 123 patient phone surveys of patients cared for at the Turtle Creek Primary Care Center inquiring about flu and COVID-19 infection status and vaccination uptake (August 26 - October 10, 2021).
Approach/Key Results Our data revealed a significant association between COVID-19 and flu vaccine acceptance. Additionally, we found a strong association between vaccine acceptance and age, with older patients being more likely to be vaccinated against COVID-19. Using multivariable logistic regression models, we assessed how flu and COVID-19 vaccine acceptance was affected by informational sources participants trusted most. In the COVID-19 models, those who cited “trusting medical professionals” had higher odds of vaccine acceptance while participants who cited “trusting social media” had significantly decreased odds of vaccine acceptance.
Conclusion Our study revealed significant trends for flu and COVID-19 vaccine acceptance by sociodemographic factors and trust in the medical system. Using these data, we can create future interventions to overcome vaccine hesitancy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not require nor receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study design and survey were given approval by the Quality Improvement Review Committee at the University of Pittsburgh Medical Center (UPMC; Pittsburgh, PA). The UPMC Quality Improvement Committee reviewed this project and deemed that it did not meet the federal definition of research according to 45 CFR 46.102(l) and did not require additional Institutional Review Board (IRB) oversight. The ethics of this study were also reviewed by the UPMC Quality Improvement Committee and deemed exempt from IRB review.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* co-first authors
Senior author: Allie Dakroub, MD, MS, Assistant Professor of Medicine, University of Pittsburgh School of Medicine, Staff Physician, General Internal Medicine, 1218 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, Phone: 313-478-0600, Email: dakroubah{at}upmc.edu
Data Availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.